Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 26 May 2021 for Tonix Pharmaceuticals Holding Corp., €4,572.
Filing timeline
BuySaleDaniel Wintner Goodman
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-45.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Daniel Wintner Goodman: trading record in brief
Only one filing by Daniel Wintner Goodman is known so far (26 May 2021): an open-market purchase, €4,572, in Tonix Pharmaceuticals Holding Corp. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel Wintner Goodman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
5,000 shares@ US$1.12100.0% of flowCommon StockSEC:0001387131-21-006089:0
Canonical exit: 23 Aug 2021 (T+90)
1 of 1 declaration
